The present study shows that MTC post-treatment reduces the expression of Bim, cleaved-caspase-12, IP3, GRP78 and CHOP protein levels (Figure 7b,c), and the results are consistent with previous studies. This evidence concerns the gene DDIT3 and medullary thyroid gland carcinoma.